Literature DB >> 28939986

Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET".

Regine Kluge1, Sally Barrington2, Lars Kurch3, Dirk Hasenclever4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28939986     DOI： 10.1007/s00259-017-3826-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET.

Authors:  Eric Laffon; Roger Marthan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-18       Impact factor: 9.236

2.  Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Authors:  Salvatore Annunziata; Annarosa Cuccaro; Maria Lucia Calcagni; Stefan Hohaus; Alessandro Giordano; Vittoria Rufini
Journal:  Ann Nucl Med       Date:  2016-05-31       Impact factor: 2.668

3.  qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.

Authors:  Dirk Hasenclever; Lars Kurch; Christine Mauz-Körholz; Andreas Elsner; Thomas Georgi; Hamish Wallace; Judith Landman-Parker; Angelina Moryl-Bujakowska; Michaela Cepelová; Jonas Karlén; Ana Álvarez Fernández-Teijeiro; Andishe Attarbaschi; Alexander Fosså; Jane Pears; Andrea Hraskova; Eva Bergsträsser; Auke Beishuizen; Anne Uyttebroeck; Eckhard Schomerus; Osama Sabri; Dieter Körholz; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

Review 4.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

Review 5.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236
  5 in total
  1 in total

Review 1.  Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.

Authors:  Kathleen M McCarten; Helen R Nadel; Barry L Shulkin; Steve Y Cho
Journal:  Pediatr Radiol       Date:  2019-10-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.